Literature DB >> 15727662

Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser.

N C Zeitouni, K Dawson, R T Cheney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15727662     DOI： 10.1111/j.1365-2133.2005.06307.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

Authors:  Caroline Aspord; Laetitia Tramcourt; Claire Leloup; Jean-Paul Molens; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

Review 2.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

Review 3.  Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

Authors:  Julie Charles; Laurence Chaperot; Dimitri Salameire; Jérémy Di Domizio; Caroline Aspord; Rémy Gressin; Marie-Christine Jacob; Marie-Jeanne Richard; Jean-Claude Beani; Joel Plumas; Marie-Thérèse Leccia
Journal:  Eur J Dermatol       Date:  2009-10-22       Impact factor: 3.328

4.  Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.

Authors:  Kelly C G ManfrereC; Marina P Torrealba; Denis R Miyashiro; Nátalli Z Pereira; Fabio S Y Yoshikawa; Luana de M Oliveira; Jade Cury-Martins; Alberto J S Duarte; José A Sanches; Maria N Sato
Journal:  Oncotarget       Date:  2017-09-18

5.  Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.

Authors:  Hansje-Eva Teulings; Esther P M Tjin; Karina J Willemsen; Stephanie van der Kleij; Sylvia Ter Meulen; E Helen Kemp; Gabrielle Krebbers; Carel J M van Noesel; Cornelis L M C Franken; Jan W Drijfhout; Cornelis J M Melief; Ludmila Nieuweboer-Krobotova; Omgo E Nieweg; Jos A van der Hage; J P Wietze van der Veen; Germaine N Relyveld; Rosalie M Luiten
Journal:  Oncoimmunology       Date:  2018-01-15       Impact factor: 8.110
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.